Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 18, 2025

Johnson & Johnson to acquire Halda Therapeutics for $3.05bn

Johnson & Johnson (J&J) has signed a definitive agreement for the acquisition of Halda Therapeutics (Halda) in a $3.05bn cash deal.

Continue
Halda is a biotech company that utilises a platform known as Regulated Induced Proximity Targeting Chimera (RIPTAC). Credit: CDC on Unsplash.
November 17, 2025

Sofinnova closes €650m healthcare fund for early-stage ventures

The fund draws on the strength of its experienced team. Credit: Sofinnova Partners.
November 14, 2025

Eisai and Biogen report Leqembi’s MHRA approval for Alzheimer’s

Leqembi for IV maintenance dosing is approved once every four weeks to treat early Alzheimer’s. Credit: Robina Weermeijer on Unsplash

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. BostonGene and Kyoto University link on oesophageal cancer drug
  2. March Bio’s MB‑105 gains FDA RMAT for CD5+ T‑cell lymphoma
  3. Novartis opens California site for RLT manufacturing
  4. SanegeneBio and Lilly sign RNAi licence deal for metabolic diseases
  5. Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz

PRESS RELEASES

Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities
Gerresheimer at CPHI Frankfurt 2025
Gerresheimer at CPHI Frankfurt 2025
Pharmaceutical Business Review
LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
LTS Wins Funding from BARDA’s Patch Forward Prize Competition for Two artnerships
LTS Wins Funding from BARDA’s Patch Forward Prize Competition for Two artnerships
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds

Suppliers

Whitepapers

Pharmaceutical Business Review
EVERIC® Pure – The Safe Option Right from the Start
Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme